Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry
Academic Article
Publication Date:
2017
abstract:
We aimed to provide data on golimumab real-life use in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) from a multicentre observational registry of Northern Italy.
Iris type:
14.a.1 Articolo su rivista
Keywords:
Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Registries; Retrospective Studies; Spondylitis, Ankylosing; Time Factors; Treatment Outcome
List of contributors:
Manara, Maria; Caporali, Roberto; Favalli, Ennio G; Grosso, Vittorio; Atzeni, Fabiola; Sarzi Puttini, Piercarlo; Gorla, Roberto; Bazzani, Chiara; Fusaro, Enrico; Pellerito, Raffaele; Rocchetta, Pier Andrea; Sinigaglia, Luigi
Published in: